British Columbia Investment Management Corp Jazz Pharmaceuticals PLC Transaction History

British Columbia Investment Management Corp

$16 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$115.19 - $132.77 $22,692 - $26,155	197 Added 2.85%	7,103 $855,000
Q4 2023 Feb 14, 2024	BUY	$114.26 - $136.0 $122,715 - $146,064	1,074 Added 18.42%	6,906 $849,000
Q3 2023 Nov 14, 2023	BUY	$122.0 - $145.31 $27,572 - $32,840	226 Added 4.03%	5,832 $754,000
Q1 2023 May 12, 2023	BUY	$133.98 - $160.47 $15,943 - $19,095	119 Added 2.17%	5,606 $820,000
Q4 2022 Feb 10, 2023	SELL	$129.72 - $159.85 $88,339 - $108,857	-681 Reduced 11.04%	5,487 $874,000
Q3 2022 Nov 10, 2022	SELL	$126.59 - $161.18 $118,868 - $151,348	-939 Reduced 13.21%	6,168 $822,000
Q2 2022 Aug 12, 2022	SELL	$141.59 - $168.66 $337,267 - $401,748	-2,382 Reduced 25.1%	7,107 $1.11 Million
Q1 2022 May 12, 2022	SELL	$129.64 - $160.7 $168,402 - $208,749	-1,299 Reduced 12.04%	9,489 $1.48 Million
Q4 2021 Feb 11, 2022	SELL	$119.87 - $145.67 $55,260 - $67,153	-461 Reduced 4.1%	10,788 $1.37 Million
Q2 2021 Aug 09, 2021	BUY	$160.2 - $186.42 $336,580 - $391,668	2,101 Added 22.97%	11,249 $2 Million
Q1 2021 Apr 30, 2021	SELL	$150.19 - $173.5 $33,041 - $38,170	-220 Reduced 2.35%	9,148 $1.5 Million
Q4 2020 Feb 02, 2021	SELL	$140.71 - $165.05 $31,941 - $37,466	-227 Reduced 2.37%	9,368 $1.55 Million
Q3 2020 Nov 10, 2020	BUY	$105.46 - $144.13 $63,275 - $86,478	600 Added 6.67%	9,595 $1.37 Million
Q2 2020 Aug 12, 2020	BUY	$95.68 - $121.88 $268,382 - $341,873	2,805 Added 45.32%	8,995 $993,000
Q1 2020 May 13, 2020	SELL	$87.74 - $152.74 $627,428 - $1.09 Million	-7,151 Reduced 53.6%	6,190 $617,000
Q4 2019 Feb 12, 2020	SELL	$117.65 - $153.73 $7.22 Million - $9.44 Million	-61,383 Reduced 82.15%	13,341 $1.99 Million
Q3 2019 Nov 14, 2019	BUY	$125.18 - $143.24 $2.54 Million - $2.91 Million	20,311 Added 37.33%	74,724 $9.58 Million
Q2 2019 Aug 12, 2019	BUY	$125.55 - $144.48 $4.77 Million - $5.49 Million	37,975 Added 231.02%	54,413 $7.76 Million
Q1 2019 May 08, 2019	SELL	$121.81 - $142.95 $492,112 - $577,518	-4,040 Reduced 19.73%	16,438 $2.35 Million
Q4 2018 Feb 13, 2019	BUY	$115.94 - $166.74 $235,126 - $338,148	2,028 Added 10.99%	20,478 $2.54 Million
Q3 2018 Nov 13, 2018	SELL	$161.01 - $180.57 $1.08 Million - $1.21 Million	-6,721 Reduced 26.7%	18,450 $3.1 Million
Q2 2018 Aug 09, 2018	BUY	$146.33 - $183.18 $384,701 - $481,580	2,629 Added 11.66%	25,171 $4.34 Million
Q1 2018 May 15, 2018	SELL	$135.59 - $157.16 $189,148 - $219,238	-1,395 Reduced 5.83%	22,542 $3.4 Million
Q4 2017 Feb 20, 2018	SELL	$131.06 - $150.39 $671,289 - $770,297	-5,122 Reduced 17.63%	23,937 $3.22 Million
Q3 2017 Nov 14, 2017	BUY	$142.62 - $155.6 $4.14 Million - $4.52 Million	29,059	29,059 $4.25 Million

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account